✓ Last verified: March 1, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff
Known For: Veteran-founded Chesapeake psychiatric practice — Justin Ray, a retired Navy veteran and PMHNP-BC, leads a three-clinician team delivering insurance-covered Spravato with particular experience in veteran and complex psychiatric care.
| Review Scores | Veteran-founded psychiatric practice in South Chesapeake with three board-certified PMHNPs |
| Location | Chesapeake, VA |
| Address | 200 Carmichael Way, Suite 604, Chesapeake, VA 23322 |
| Phone | Contact via website |
| Website | southchesapeakepsychiatry.com |
| Treatments | Spravato (Esketamine) Nasal Spray, Psychiatric Medication Management, Complex Care |
| Conditions Treated | Treatment-Resistant Depression, Acute Suicidal Ideation, Major Depressive Disorder |
| Cost | Contact for pricing |
| Insurance | Insurance accepted for Spravato |
| Clinical Lead | Justin Ray, PMHNP-BC (Founder, Navy Veteran); Amanda Snow, PMHNP-BC; Alysha Cunningham, PMHNP-BC |
HealingMaps Take: South Chesapeake Psychiatry brings something structurally valuable to the Hampton Roads mental health market: a Navy-veteran-founded practice with direct cultural competency for the region’s military population. Justin Ray, PMHNP-BC, a retired Navy veteran, founded the practice specifically to provide complex psychiatric care in an area with one of the highest concentrations of active-duty and retired military personnel in the country. That matters clinically because veterans with treatment-resistant depression often have complex presentations — PTSD, traumatic brain injury, chronic pain — that benefit from providers familiar with military service contexts. The three-clinician team (Justin Ray, Amanda Snow with 25 years in mental health, Alysha Cunningham) provides enough clinical depth to handle multiple Spravato patients simultaneously while maintaining personalized care. Insurance acceptance for Spravato is a meaningful differentiator in a market where many practices are cash-only. The structured twice-weekly induction (month 1), weekly maintenance (month 2), and individualized schedule thereafter follows the FDA framework. Two-to-three-hour session length with observation and recovery reflects appropriate clinical monitoring. The Carmichael Way location in the southern Chesapeake/Great Bridge corridor serves Greenbrier, Great Bridge, Western Branch, and the southern Hampton Roads metro, filling a geographic gap for patients who don’t want to drive to Norfolk or Virginia Beach.
Market Position: South Chesapeake Psychiatry is a Spravato-certified clinic in the Chesapeake metro. Spravato (esketamine) is the FDA-approved ketamine treatment that most commercial insurance plans cover after prior authorization — unlike cash-pay IV ketamine.
Industry pricing reference. South Chesapeake Psychiatry has not published specific per-session pricing — contact the clinic directly for a quote. The calculator above shows typical metro-level cost estimates across protocols, not this clinic’s specific prices.
| Protocol | Typical Industry Cost | Offered Here |
|---|---|---|
| IV Ketamine | $350–$650/session | — |
| Spravato (esketamine) | $0–$250 copay (insured) | ✓ Yes |
| IM Ketamine | $250–$400/injection | — |
| KAP (with therapist) | $400–$1,200/session | — |
| At-home troches | $150–$300/month | — |
This 2-question summary is matched to the protocols and conditions South Chesapeake Psychiatry treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.
Yes — South Chesapeake Psychiatry offers Spravato, which means they’re FDA REMS-certified and maintain the required two-hour in-office monitoring window after each dose. Spravato is the primary insurance-covered ketamine option for treatment-resistant depression. Worth confirming the prior-authorization timeline before booking your first session.
South Chesapeake Psychiatry treats depression via Spravato (FDA-approved for TRD). The Spravato pathway is the most likely to obtain commercial insurance coverage. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.
Leave a Reply